Mayo Clinic Q&A: Cardiac Risks of Off-Label Drugs to Treat COVID-19

Everyone
  • 1 video | 15m 50s
Rating 4.7 of 37 users Rating 4.7 of 37 users (37)
A study published recently in Mayo Clinic Proceedings details information about potential cardiac side effects when using off-label drugs to treat COVID-19. Off-label means the drug has been approved by the Food and Drug Administration to treat a different condition. Some of the off-label drugs being used to treat COVID-19 have a risk of sudden cardiac arrest and death. (Published 04/08/2020)

YOU MIGHT ALSO LIKE

Audiobook COVID-19 Miniseries: Mayo Clinic Q&A -- Fostering Resilience In Children During COVID-19
Audiobook COVID-19 Miniseries: How to Mitigate Drug-Induced Sudden Cardiac Death From Hydroxychloroquine
Audiobook Mayo Clinic Q&A: Fighting COVID-19 with Mayo Clinic Laboratories

PEOPLE WHO VIEWED THIS ALSO VIEWED THESE

Course CompTIA Security+ Crash Course Bootcamp (Sept 2023): Session 3 Replay
Rating 5.0 of 2 users Rating 5.0 of 2 users (2)
Course Embracing Change at Work
Rating 4.5 of 3960 users Rating 4.5 of 3960 users (3960)
Course Making the Most of an Organizational Change
Rating 4.6 of 1899 users Rating 4.6 of 1899 users (1899)